-
Akụkọ na-atọ ụtọ | Ihe nrụpụta API Semaglutide kacha ukwuu na China gafere nyocha FDA US
Site na Ọgọst 26 ruo Ọgọst 30, 2024, ụlọ nrụpụta peptide nke JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., gafere nyocha saịtị nke US Food and Drug Administration (FDA) mere nke ọma. Nlele ahụ kpuchiri ebe ndị dị mkpa ...GỤKWUO -
Ngosipụta ọgwụ CPHI Milan 2024
01. Nlebanya ngosi On October 8th, 2024 CPHI Worldwide Pharmaceutical ngosi malitere na Milan. Dị ka otu n'ime ihe omume kachasị mkpa kwa afọ na ụlọ ọrụ ọgwụ zuru ụwa ọnụ, ọ dọtara ndị sonyere na mba na mpaghara 166. N'ofe...GỤKWUO -
Akụkọ na-atọ ụtọ | JYMed's Liraglutide API na-anata Asambodo WC
Na Ọktọba 12, 2024, JYMed's Liraglutide API nwetara akwụkwọ nkwenye Ederede (WC), na-aka akara nzọụkwụ dị oke mkpa maka mbupụ API na-aga nke ọma n'ahịa EU. WC (Nkwenye Ederede)...GỤKWUO -
Akụkọ na-atọ ụtọ: JYMed's Leuprorelin Acetate gafere nyocha ndebanye aha ọgwụ ọjọọ.
N'oge na-adịbeghị anya, JYMed Technology Co., Ltd. mara ọkwa na Leuprorelin Acetate, nke onye enyemaka ya na-emepụta Hubei JX Bio-Pharmaceutical Co., Ltd., agafewo nyocha nke ndebanye aha ọgwụ. Ahịa ọgwụ izizi...GỤKWUO -
Ekele JYMed's Tirzepatide emechaala ntinye akwụkwọ US-DMF
JYMed Technology Co., Ltd. nwere obi ụtọ ịkpọsa na ngwaahịa ya, Tirzepatide, emechaala ndebanye aha Drug Master File (DMF) na US FDA (nọmba DMF: 040115) wee nata FDA's Acknowl ...GỤKWUO -
JYMed gara PCT 2024 na Shanghai
PCT2024 Personal Care Technology Summit & Exhibition bụ ihe omume dị oke mkpa na mpaghara Asia-Pacific, na-elekwasị anya na mgbanwe teknụzụ na ihe ngosi na ụlọ ọrụ nlekọta onwe onye. Nzukọ ahụ ga-ekpuchi akụkụ dị iche iche nke ụlọ ọrụ nlekọta onwe onye, gụnyere nkà na ụzụ na ...GỤKWUO -
JYMed Peptide na-akpọ gị òkù ka ị gaa ihe ngosi ihe ịchọ mma Korea 2024
Ọnọdụ: Ebe ngosi ihe ngosi mba ụwa nke Korea: Julaị 24-26, 2024 Oge: 10:00 AM – 5:00 PM okwu: COEX ngosi Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics bụ a ndị isi otu ihe ngosi mba ụwa na ihe nlekọta onwe onye ...GỤKWUO -
Akwụkwọ akụkọ Iwu ọhụrụ
1. A ga-amachibido iwu ndebanye aha FDA ọhụrụ maka ịchọ mma ịchọ mma US na-enweghị ndebanye aha FDA site na ire ere. Dị ka Modernization of Cosmetics Regulation Act nke 2022, nke President Biden bịanyere aka na ya na Disemba 29, 2022, ihe ịchọ mma niile ebupụ na United States ga-abụrịrị FDA. -debanye aha...GỤKWUO -
Ọkwa Ememme Mmiri
Biko mee ka amara na a ga-emechi ụlọ ọrụ anyị site na Feb. 4 ruo Feb.18 n'ihi Ememe Mmiri. A ga-anabata iwu ọ bụla mana agaghị ahazi ya ruo Feb.19, ụbọchị azụmaahịa mbụ mgbe Ememme Mmiri gasịrị. Ndo maka nsogbu ọ bụla kpatara.GỤKWUO -
2023 API 88th CHINA
Ozi gbasara JYMed na 2023 API CHINA 【on-saịtị】 N'okpuru nduzi nke Vice General Manager Zhi Qin, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọkarị JYMed) sonyere na ihe ngosi a dị ebube. JYMed gosipụtara ngwaahịa bara uru Semaglutide, Liraglutide, Tirzepatide, O ...GỤKWUO -
Nabata izute anyị na ihe ngosi API na ngwaahịa Qindao China JYMed: N4K32
GỤKWUO -
JYMed jikọtara gị na PCHi
Mgbe afọ abụọ nke atụmanya gasịrị, 2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) mere na Guangzhou Canton Fair Complex na February 15-17, 2023. ...GỤKWUO -
Semeglutide API nke Shenzhen JYMed nabatara nke mbụ ogbe nke anụ ụlọ NMPA na debara aha na US FDA (DMF No. 036009) na ọnọdụ "A".
Na Mee 2022, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọ JYMed peptide) nyefere ngwa maka ndebanye aha API semaglutide na US Food and Drug Administration (FDA) (nọmba ndebanye aha DMF: 036009), Ọ gafere. nyochaa iguzosi ike n'ezi ihe, na ọnọdụ dị ugbu a i...GỤKWUO -
Peptides ọla kọpa: Uru nlekọta anụ ahụ na ntutu na otu esi eji ha
Anyị na-agụnye ngwaahịa ndị anyị chere na ndị na-agụ anyị ga-ahụ na ọ bara uru. Anyị nwere ike nweta obere ọrụ ma ọ bụrụ na ịzụrụ ihe site na njikọ dị na ibe a. Nke a bụ usoro anyị. Peptides bụ amino asịd na-eme n'ezie nke na-enyere aka ịmepụta collagen na elastin, anụ ahụ njikọ abụọ na-ahụ maka s ...GỤKWUO -
Ozempic (Semaglutide) ịgba ọgwụ: ojiji, mmetụta akụkụ, usoro onunu ogwu
Erica Prouty, PharmD, bụ ọkachamara n'ịzụ ọgwụ na-enyere ndị ọrịa aka na ọgwụ na ụlọ ahịa ọgwụ na North Adams, Massachusetts. N'ime ọmụmụ anụmanụ na-abụghị nke mmadụ, egosiri semaglutide na-akpata ụbụrụ thyroid C-cell na òké. Agbanyeghị, amabeghị ma ihe egwu a gbasara mmadụ….GỤKWUO -
Mwepu nke acid fatty na nchọpụta nke peptide na ọgwụ protein
Daalụ maka ileta Nature.com. Ụdị ihe nchọgharị ị na-eji nwere nkwado CSS nwere oke. Maka ahụmịhe kachasị mma, anyị na-akwado ka ị jiri ihe nchọgharị emelitere (ma ọ bụ gbanyụọ ọnọdụ ndakọrịta na Internet Explorer). Ka ọ dị ugbu a, iji hụ na nkwado na-aga n'ihu, anyị ga-enye saịtị ahụ na-enweghị s ...GỤKWUO -
Klas I ọhụrụ ọgwụ JYMed enweela ọganihu dị ukwuu, a na-atụ anya na Laipushutai ga-abụ ahịrị mbụ nke ọgwụ UC.
Na June 29, 2017, mmepe nke Laipushutai, klas m nkà mmụta ọgwụ ọhụrụ na nkwado nkwado nke JYMed na Guangzhou Linkhealth Medical Technology Co., Ltd., emeela ọganihu dị ukwuu. Ndị CFDA anabatala nkwupụta IND ọgwụ ahụ. JYMed na Guangzhou Lin…GỤKWUO -
Akụkọ & Ihe Omume Ngalaba Ngwaahịa Peptide dị na JYMed agafeela nyocha saịtị n'enweghị ntụpọ sitere na FDA.
Jiri obi ụtọ kelee ngalaba ngwaahịa ngwaahịa Polypeptide anyị maka ịgafe nyocha US FDA na saịtị na "nrụmahụ efu"! Ịgafe FDA na saịtị na "nrụrụ efu" bụ nnukwu ihe omume na akụkọ mmepe cGMP anyị. Ọ bụghị naanị na ọ pụtara na API anyị nwere obt...GỤKWUO